|
|
|
|
|
|
最高研发阶段临床2期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
A First in Human, Randomized, Double-Blind Study to Assess Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Effects of HTD4010 in Healthy Participants
To investigate safety and tolerability of HTD4010 after single ascending doses (SAD) in healthy volunteers
100 项与 NGFB x TLR4 相关的临床结果
100 项与 NGFB x TLR4 相关的转化医学
0 项与 NGFB x TLR4 相关的专利(医药)